Clinical implications of elevated serum interleukin-6 in IgG4-related disease
暂无分享,去创建一个
K. Uchida | A. Nishio | K. Okazaki | T. Ikeura | Takashi Ito | Toshihiro Tanaka | N. Tanigawa | Takashi Yamaguchi | T. Tomiyama | Y. Ando | Y. Hori | Koh Nakamaru | T. Fukui | M. Masuda | S. Tsukuda | Manami Ikemune | M. Yanagawa | Rika Terasawa
[1] M. Kawakami,et al. Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature , 2019, Immunologic Research.
[2] A. Kawashima,et al. Inflammatory features, including symptoms, increased serum interleukin-6, and C-reactive protein, in IgG4-related vascular diseases , 2018, Heart and Vessels.
[3] T. Takeuchi,et al. Distinct features distinguishing IgG4-related disease from multicentric Castleman’s disease , 2017, RMD Open.
[4] Y. Kawabata,et al. Comparison of clinical and pathological features of lung lesions of systemic IgG4‐related disease and idiopathic multicentric Castleman's disease , 2017, Histopathology.
[5] K. Uchida,et al. IgG4-related Disease Involving Multiple Organs with Elevated Serum Interleukin-6 Levels. , 2016, Internal medicine.
[6] S. Oda,et al. Interleukin-6 Levels Act as a Diagnostic Marker for Infection and a Prognostic Marker in Patients with Organ Dysfunction in Intensive Care Units , 2016, Shock.
[7] H. Sugimoto,et al. Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis , 2016, Gut.
[8] J. Stone,et al. Predictors of disease relapse in IgG4-related disease following rituximab. , 2016, Rheumatology.
[9] Dermot Kelleher,et al. Idiopathic multicentric Castleman's disease: a systematic literature review. , 2016, The Lancet. Haematology.
[10] K. Harada,et al. Multicentric Castleman Disease With Tubulointerstitial Nephritis Mimicking IgG4-related Disease: Two Case Reports , 2016, The American journal of surgical pathology.
[11] P. Gual,et al. Immunoglobulin G4-associated autoimmune hepatitis may be found in Western countries. , 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[12] Y. Zen,et al. Idiopathic multicentric Castleman's disease: a clinicopathologic study in comparison with IgG4-related disease , 2015, Oncotarget.
[13] A. Komatsuda,et al. Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease , 2014, Modern rheumatology.
[14] T. Takenouchi,et al. Purinergic signaling via P2Y receptors up-mediates IL-6 production by liver macrophages/Kupffer cells. , 2014, The Journal of toxicological sciences.
[15] H. Ono,et al. Reduction of splenic volume by steroid therapy in cases with autoimmune pancreatitis , 2013, Journal of Gastroenterology.
[16] K. Uchida,et al. Current concept and diagnosis of IgG4-related disease in the hepato-bilio-pancreatic system , 2013, Journal of Gastroenterology.
[17] Wei-Chih Liao,et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis , 2012, Gut.
[18] J. Chan,et al. Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity. , 2012, Seminars in diagnostic pathology.
[19] T. Hibi,et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 , 2012, Modern rheumatology.
[20] K. Uchida,et al. Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis , 2011, Journal of Gastroenterology.
[21] Y. Nakanuma,et al. Clinical significance of immunoglobulin G4-associated autoimmune hepatitis , 2011, Journal of Gastroenterology.
[22] Kohjiro Ueki,et al. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus , 2010, Journal of diabetes investigation.
[23] S. Lonial,et al. Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman's disease. , 2010, Journal of Clinical Oncology.
[24] B. Petersen,et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. , 2010, Gastroenterology.
[25] M. Falconi,et al. Autoimmune Pancreatitis: Differences Between the Focal and Diffuse Forms in 87 Patients , 2009, The American Journal of Gastroenterology.
[26] Hiroyuki Yamamoto,et al. The analysis of interleukin-6 in patients with systemic IgG4-related plasmacytic syndrome--expansion of SIPS to the territory of Castleman's disease. , 2009, Rheumatology.
[27] E. Godfrey,et al. Splenomegaly: investigation, diagnosis and management. , 2009, Blood reviews.
[28] H. Asaoku,et al. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease , 2009, Modern Pathology.
[29] D. S̆timac,et al. Prognostic Values of IL-6, IL-8, and IL-10 in Acute Pancreatitis , 2006, Journal of clinical gastroenterology.
[30] O. Ueda,et al. Anti-interleukin 6 (IL-6) receptor antibody suppresses Castleman's disease like symptoms emerged in IL-6 transgenic mice. , 2002, Cytokine.
[31] H. Tilg,et al. Serum levels of cytokines in chronic liver diseases. , 1992, Gastroenterology.
[32] J. Miyazaki,et al. IgG1 plasmacytosis in interleukin 6 transgenic mice. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[33] Kurose Nozomu. Clinicopathological Analysis between IgG4-related and Non-IgG4-related Diseases Occurring in Various Organs and Tissues: Re-evaluation of Comprehensive Diagnostic Criteria and Usefulness of Interleukin-6 Immunostaining , 2016 .
[34] K. Okazaki,et al. Comprehensive Diagnostic Criteria for IgG4-Related Disease , 2014 .
[35] K. Uchida,et al. Effective steroid pulse therapy for the biliary stenosis caused by autoimmune pancreatitis. , 2007, The American journal of gastroenterology.
[36] Y. Shima,et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. , 2000, Blood.
[37] K. Batts,et al. The nature and prognostic implications of autoimmune hepatitis with an acute presentation. , 1994, Journal of hepatology.